Paper42828343PubMed
Four Weeks of Biologic Treatment are Sufficient to Normalize Blunted HPA-Axis Activity and Significantly Improve Psychological Burden in Patients with Psoriasis.
Krefting F and 12 others. Psoriasis (Auckl), 2026.
Cite this record
ConductScience Library. Four Weeks of Biologic Treatment are Sufficient to Normalize Blunted HPA-Axis Activity and Significantly Improve Psychological Burden in Patients with Psoriasis. Papers, record 42828343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42828343
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Four Weeks of Biologic Treatment are Sufficient to Normalize Blunted HPA-Axis Activity and Significantly Improve Psychological Burden in Patients with Psoriasis.
- Journal
- Psoriasis (Auckl)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-05
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14572876 | Reproducibility of the circadian rhythms of serum cortisol and melatonin in healthy subjects: a study of three different 24-h cycles over six weeks. | Life Sci | 2003 | https://conductscience.org/library/papers/14572876 | PubMed |
| 2 | 24402217 | Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. | Braz J Psychiatry | 2013 | https://conductscience.org/library/papers/24402217 | PubMed |
| 3 | 34806209 | A brief screening tool for depression in psoriasis patients: The Two Questions Test in clinical practice. | J Dermatol | 2022 | https://conductscience.org/library/papers/34806209 | PubMed |
| 4 | 40861201 | The role of psychological stress in the pathogenesis of psoriasis. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40861201 | PubMed |
| 5 | 34834421 | Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis. | J Pers Med | 2021 | https://conductscience.org/library/papers/34834421 | PubMed |
| 6 | 6668417 | A global measure of perceived stress. | J Health Soc Behav | 1983 | https://conductscience.org/library/papers/6668417 | PubMed |
| 7 | 27928931 | Differentiating anxiety and depression: the State-Trait Anxiety-Depression Inventory. | Cogn Emot | 2018 | https://conductscience.org/library/papers/27928931 | PubMed |
| 8 | 20713823 | The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. | Arch Dermatol | 2010 | https://conductscience.org/library/papers/20713823 | PubMed |
| 9 | 37488456 | Interleukin-17 as a key player in neuroimmunometabolism. | Nat Metab | 2023 | https://conductscience.org/library/papers/37488456 | PubMed |
| 10 | 41115620 | Hypothalamic pituitary adrenal axis hormone changes during IL-17A inhibition with secukinumab in patients with psoriasis. | Clin Immunol | 2026 | https://conductscience.org/library/papers/41115620 | PubMed |
| 11 | 37084792 | The Perceived Stress Scale as a Measure of Stress: Decomposing Score Variance in Longitudinal Behavioral Medicine Studies. | Ann Behav Med | 2023 | https://conductscience.org/library/papers/37084792 | PubMed |
| 12 | 36065538 | Circadian cortisol profiles and hair cortisol concentration in patients with psoriasis: associations with anxiety, depressive symptomatology and disease severity | Eur J Dermatol | 2022 | https://conductscience.org/library/papers/36065538 | PubMed |
| 13 | 31887225 | A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial. | Br J Dermatol | 2020 | https://conductscience.org/library/papers/31887225 | PubMed |
| 14 | 32146709 | Stigmatization and Quality of Life in Patients with Psoriasis. | Dermatol Ther (Heidelb) | 2020 | https://conductscience.org/library/papers/32146709 | PubMed |
| 15 | 27752078 | Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. | Mol Psychiatry | 2018 | https://conductscience.org/library/papers/27752078 | PubMed |
| 16 | 30628634 | Patients with Moderate to Severe Psoriasis Associate with Higher Risk of Depression and Anxiety Symptoms: Results of a Multivariate Study of 300 Spanish Individuals with Psoriasis. | Acta Derm Venereol | 2019 | https://conductscience.org/library/papers/30628634 | PubMed |
| 17 | 24288511 | Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment. | ScientificWorldJournal | 2013 | https://conductscience.org/library/papers/24288511 | PubMed |
| 18 | 22271232 | [Mood in the German population: norms of the Multidimensional Mood Questionnaire MDBF]. | Psychother Psychosom Med Psychol | 2012 | https://conductscience.org/library/papers/22271232 | PubMed |
| 19 | 17240656 | Stepwise gatekeeping procedures in clinical trial applications. | Biom J | 2006 | https://conductscience.org/library/papers/17240656 | PubMed |
| 20 | 13688369 | An inventory for measuring depression. | Arch Gen Psychiatry | 1961 | https://conductscience.org/library/papers/13688369 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42828343
GET https://conductscience.org/api/papers/v1/42828343/references?page=2